Honghan Qiao

3PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 08, 2026
Updated Real-World Outcomes with Brentuximab Vedotin in Chinese Lymphoma Patients: A Multicenter, Retrospective Study.

|Jan 04, 2026
A first-line regimen combining Bruton's tyrosine kinase and programmed cell death protein-1 inhibitors with chemotherapy excluding methotrexate achieves high response rates in primary central nervous system lymphoma.

Wanyue Zhao, Ling Li, Xiaorui Fu

|Nov 17, 2023
Brentuximab vedotin in treating Chinese patients with lymphoma: A multicenter, real-world study.

Xudong Zhang, Honghan Qiao, Xiaofei Chai

Pageof 1

Frequent Collaborators

2 joint publications

Mingzhi Zhang

1 joint publications

Wanyue Zhao

1 joint publications

Shanshan Ma

1 joint publications

Qingjiang Chen